Patients Waiting Months for 'Last Chance' CAR T-Cell Therapy
Supply shortages and limited manufacturing capacity are leaving myeloma patients waiting months for CAR T-cell therapy, which offers a "last chance" after all other therapies have failed.
Medscape Medical News
source https://www.medscape.com/viewarticle/977179?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/977179?src=rss
Comments
Post a Comment